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London Regional Cancer Physics and Engineering, Canada 1 , C. Lewis 1 Purpose or Objective: Radiation safety for softer flattening filter free (FFF) treatment beams when operating at their very high dose rates should be considered over that of their flattening filter (FF) counterparts. Existing shielding is usually adequate when replacing treatment units utilizing beams of FF only with FFF-beams of the same nominal energy(1). However, depending upon the existing shielding composition and thickness, workload, and occupancy factors, the instantaneous dose rate (IDR) may present a radiation safety concern.
Material and Methods:
A generalized analysis is presented with regards to replacing a unit which has only FF-beams to one with FFF-beams in a pre-existing bunker. Extra focus is placed on the situation that radiation levels around the treatment bunker are already at the radiation safety threshold for the unit being replaced. This threshold condition varies with the radiation safety regulations of the land. For example, the Canadian Nuclear Safety Commission (CNSC) imposes a condition that the IDR be less than 25 μSv/h to deem an area uncontrolled(3). The United States National Regulatory Council (US NRC) regulates the time averaged dose rate (TADR) to be less than 20μSv in any one hour(2).
Results:
It is demonstrated that in switching to FFF-beam treatment units that protection using existing shielding is maintained for annual and weekly equivalent dose protection levels. However, it is possible for the CNSC IDR condition to be exceeded at the highest dose rates for FFF-beams. Thus shielding modification should be considered along with the ALARA principle(4). An analysis of the latter point is presented in general and by example from such a treatment unit replacement at the London Regional Cancer Program. The US NRC regulation is not as stringent as the Canadian condition and is almost impossible to exceed if the conditions before replacement were met. The analysis of this result is presented in general.
Conclusion:
Care must be taken when considering thereplacement of radiation treatment units with FF-beams to those with FFF-beamswith respect to radiation protection. Radiation protection from the existingshielding is maintained for annual and weekly protection levels. However, IDR may present a radiation safety concern dependingupon radiation safety regulations in the country of its location. In Canada,the possibility exists that this threshold can be exceeded. The US NRCcondition is almost impossible to exceed. 
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Purpose or Objective:
In image-guided radiotherapy, imaging dose varies greatly with the imaging technique. We here present imaging doses from planar and cone-beam CT (CBCT) imaging for three different on-board imaging techniques: the treatment beam line (TBL, 6 MV), a dedicated imaging beam line termed kView of nominally 1 MV (IBL), and a kilovoltage system (kVision) at 70-121 kV photon energy. We consider two collectives of patients with common IGRT indications: head-and-neck and prostate cancer.
Material and Methods:
In this study, we retrospectively analyzed imaging dose of 54 patients with head-and-neck cancer and 53 with prostate cancer treated in 2013. For all patients, the number of verification images (CBCT and axes) was determined, separately for the three systems (more than 1000 images). The dose for each verification image was calculated in the Philips Pinnacle treatment planning system on a 2 mm grid using the collapsed cone algorithm. We evaluated the dose maximum and dose to the organs at risk, considering the total imaging dose, and for the techniques (6 MV, IBL, kV, planar vs. CBCT) separately.
Results:
The calculated imaging doses are given in Table 1 . Both the TBL and IBL modality entail considerable imaging dose, even for orthogonal axes. The maximum dose value for each image, averaged over all prostate patients, was 14.8 cGy (6 MV CBCT)/ 2.8 cGy (19 %; 6 MV axes)/ 10.5 cGy (71 %; IBL CBCT)/ 2.1 cGy (14 %; IBL axes)/ 3.8 cGy (26 %; kV CBCT), where percentage values refer to the 6 MV CBCT dose. As can be seen, kV CBCT still amounts to 26 % the imaging dose from MV CBCT, and about twice the dose from IBL axes. Averaged over the collective of head-and-neck cancer patients, the maximum imaging dose was 8.4 cGy (6 MV CBCT)/ 2.6 cGy (31 %; 6 MV axes)/ 6.2 cGy (74 %; IBL CBCT)/ 2.3 cGy (27 %; IBL axes)/ 0.9 cGy (11 %; kV CBCT). Here, the dose reduction from axial images was not as pronounced because less monitor units were used for MV CBCT. kV CBCT reduced the dose further because of low mAs values chosen by the autoexposure mechanism.
In our clinical setting, images were acquired at every second or third treatment fraction, resulting in a total median dose from imaging of 34.6 cGy for head-and-neck, and 70.6 cGy for prostate cancer patients. The relative frequency of the techniques and the contributions of the different techniques to the total imaging dose is shown in Figure 1 .
Conclusion:
The contribution of planar images to the imaging dose is smaller than the dose due to megavoltage CBCT, but not negligible in the clinical routine due to the larger number of planar images. The kV imaging modality has very small overall contribution to the imaging dose, which mainly arises from 6 MV and IBL (the latter being more frequently employed and therefore more prominent in the dose contribution).
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A practical approach to assess cumulative dose of CBCT using standard CT dosimetry system A. Abuhaimed Purpose or Objective: In recent years, dosimetry in cone beam computed tomography (CBCT) has become an issue as the standard dose index used for CT dosimetry (CTDI100) fails to provide a satisfactory estimation of dose for CBCT scans. AAPM TG-111 proposed replacements of the CTDI100 with a measurement of a cumulative dose to address the problem. The cumulative dose for CBCT scans f(0) is a point dose measured using a small ionization chamber in the middle of a cylindrical PMMA, polyethylene, or water phantom of length ≥450 mm to achieve scatter equilibrium. Although this method overcomes the limitations of CTDI100, the use of longer phantoms is impractical in the clinical environment. A practical approach based on using the standard CT dosimetry system was introduced to assess f(0).
Material and Methods:
A function called Gx(W)100 was introduced in this study. It was defined as the ratio of f(0) to a dose index f100(150), which was proposed for CBCT dosimetry and equals the cumulative dose averaged over the length of a standard 100 mm CT pencil ionization chamber and measured within standard 150 mm long PMMA CTDI phantoms. Monte Carlo BEAMnrc and DOSXYZnrc codes have been used to simulate the On-Board Imager (OBI) system, and to calculate f100(150) and f(0). Standard 150 mm CTDI phantoms were simulated to calculate f100(150), whereas infinitely long PMMA, polyethylene, and water phantoms were used for f(0). The phantoms were in different diameters to represent head and body of an adult patient, a body polyethylene phantom being equivalent to the ICRU-AAPM phantom. f100(150) and f(0) were measured at the centre and periphery of the phantoms using beams of width 40-500 mm and beam qualities of 80-140 kV. Gx(W)100 was evaluated under different conditions with f100(150) and f(0) calculated with the same beam width (W) and at the same position (centre or periphery).
Results:
Under the different conditions, Gx(W)100 showed a weak dependency on tube voltage over the range 80-140 kV. Gx(W)100, however, was influenced by diameter and composition of the phantom. Therefore, a set of Gx(W)100 functions based on the diameter and composition was developed to assess f(0) in a given long phantom from f100(150) measurements obtained within the short phantoms. Gx(W)100 provides a practical approach to avoid the use of long phantoms, which are impractical in the clinical environment, and hence simplify the AAPM method. Since the CT dosimetry system used for f100(150) is available worldwide, this approach could help to maintain the standard equipment. The Gx(W)100 functions used in this study have been applied to a CT scanner, and showed a weak dependency on the scanner type. This gave an indication that Gx(W)100 may be comparatively independent of the type of imaging system.
Conclusion:
Gx(W)100 function was proposed in this study, and was relatively independent of tube voltage and may be independent on the scanner type. Gx(W)100 allows measurement of f(0) using the AAPM method with standard CT dosimetry equipment.
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Evaluation of organ dose according to cone-beam CT scan range using Monte Carlo simulation S.S. Lee
